Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom Read more
Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab Read more
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia Read more
Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 Read more
Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China Read more
NeurOp Receives FDA Orphan Drug Designation for NP10679 for Treatment of Subarachnoid Hemorrhage Read more
PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases Read more
Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement Read more